JOHN EDWARD ADENT Insider Trading $NEOG NEOGEN CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN EDWARD ADENT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN EDWARD ADENT. JOHN EDWARD ADENT is President & CEO in NEOGEN CORP ($NEOG) and CEO - Subsidiary in PATTERSON COMPANIES, INC. ($PDCO).

JOHN EDWARD ADENT in NEOGEN CORP

Trading Symbol: NEOG
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of JOHN EDWARD ADENT: President & CEO
Holdings: 45,906 shares
Current Value: $2,937,066
Latest Transaction: Apr 01 2021
$NEOG Market Capitalization: $2.42B
$NEOG Previous Close: $63.98

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN EDWARD ADENT in NEOGEN CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, NEOG, PDCO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM62.709,536597,907283,340
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOSellS87.099,536830,48620,08029.6 K to 20.1 K (-32.20 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM62.709,536597,90729,61620.1 K to 29.6 K (+47.49 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM63.903,362214,832292,876
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM62.7063840,003296,238
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM63.903,362214,83220,08016.7 K to 20.1 K (+20.11 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM62.7063840,00316,71816.1 K to 16.7 K (+3.97 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM63.9014,638935,368242,876
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM62.7025,8261,619,290257,514
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOSellS87.9940,4643,560,39520,08060.5 K to 20.1 K (-66.83 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM63.9014,638935,36860,54445.9 K to 60.5 K (+31.89 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM62.7025,8261,619,29045,90620.1 K to 45.9 K (+128.62 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM63.9014,638935,368242,876
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM62.7025,8261,619,290257,514
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOSellS87.9940,4643,560,39520,08060.5 K to 20.1 K (-66.83 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM63.9014,638935,36860,54445.9 K to 60.5 K (+31.89 %)
Apr 01 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM62.7025,8261,619,29045,90620.1 K to 45.9 K (+128.62 %)
Jan 08 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM51.2920,0001,025,850296,876
Jan 08 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOSellM84.1820,0001,683,69416,08036.1 K to 16.1 K (-55.43 %)
Jan 08 2021NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM51.2920,0001,025,85036,08016.1 K to 36.1 K (+124.38 %)
Oct 08 2020NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM68.307,040480,8327,040
Oct 08 2020NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM68.3076,8775,250,699316,876
Mar 27 2020NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyP58.241,750101,92016,08014.3 K to 16.1 K (+12.21 %)
Mar 27 2020NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyP65.401,51799,21214,33012.8 K to 14.3 K (+11.84 %)
Oct 15 2019NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseA63.9090,0005,751,000239,999
Aug 07 2019NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseM51.2940,0022,051,803149,999
Aug 07 2019NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOSellS69.0331,4892,173,60412,81344.3 K to 12.8 K (-71.08 %)
Aug 07 2019NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyM51.2940,0022,051,80344,3024.3 K to 44.3 K (+930.28 %)
Nov 05 2018NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOOption ExerciseA62.7090,0005,643,000190,001
Sep 28 2018NEOGNEOGEN CORPADENT JOHN EDWARDPresident & CEOBuyP73.584,300316,3944,3000 to 4.3 K

Page:   1